← Explore
Regeneron Pharmaceuticals
REGN
$963.89
per share, on-chain
What Regeneron Pharmaceuticals does
Regeneron Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes medicines for serious diseases including eye diseases, allergic and inflammatory conditions, cancer, and rare diseases, with key products such as EYLEA, Dupixent, and Libtayo.
- Industry
- Healthcare
- CEO
- Leonard S. Schleifer
- Website
- regeneron.com
Ways to own Regeneron Pharmaceuticals
There's one version of this stock on Firstshare.
OndoREGNonOur pick
Wider choice. Usually $20 minimum, and it can cost more when New York is closed.
Daily backing report (29 Oct) ↗Monthly backing report (Sep 2026) ↗
$963.89
Open, outside US hours
Price check
What a slice looks like
$10.00 buys you 0.010 of one Regeneron Pharmaceuticals share.
That's 1.0% of one share. Small, but it's yours, and it moves with the real price. One share costs $963.89.